Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial.
暂无分享，去创建一个
M. Kaminski | D. Esseltine | K. Griffith | C. Hofmeister | A. Jakubowiak | S. Lonial | T. Zimmerman | J. Laubach | P. Richardson | D. Reece | N. Raje | S. Kelley | R. Schlossman | C. Tendler | E. Campagnaro | Colleen K. Harvey | K. Anderson | Tara B. Anderson | M. Mietzel | Sandra M Wear | Jennifer Barrickman | Sandra M. Wear